- Biotechnology company Mydecine Innovations Group (OTCPK:MYCOF) on Wednesday announced a 1-for-50 reverse stock split, wherein every 50 common shares will be consolidated into 1 common share.
- The reverse stock split is expected to result in Mydecine's outstanding common shares being reduced from 268.5M to about 5.4M.
- The expected effective date of the split will be April 20, and the post-consolidation common shares will start trading on the NEO exchange as of April 21.
Mydecine Innovations Group announces 1-for-50 reverse stock split
Recommended For You
About MYCOF Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MYCOF | - | - |
Mydecine Innovations Group Inc. |